Tocagen Inc. (TOCA): Price and Financial Metrics

Tocagen Inc. (TOCA): $1.26

-0.05 (-3.82%)

POWR Rating

Component Grades













Add TOCA to Watchlist
Sign Up

Industry: Biotech



in industry

TOCA Stock Price Chart Interactive Chart >

Price chart for TOCA

TOCA Price/Volume Stats

Current price $1.26 52-week high $6.77
Prev. close $1.31 52-week low $0.42
Day low $1.22 Volume 761,400
Day high $1.50 Avg. volume 1,472,422
50-day MA $1.24 Dividend yield N/A
200-day MA $1.04 Market Cap 30.14M

Tocagen Inc. (TOCA) Company Bio

Tocagen Inc., a clinical-stage company, focuses on developing gene therapy candidates to activate a patient’s immune system against their cancer in the United States. The company is developing Toca 511 & Toca FC that is in Phase II/III clinical trial for patients with recurrent high grade glioma (HGG); and Phase Ib clinical trial for the intravenous treatment of metastatic colorectal, pancreatic, breast, lung, melanoma, and renal cancers, as well as in preclinical stage for newly diagnosed HGG. The company was founded in 2007 and is based in San Diego, California.

TOCA Latest News Stream

Event/Time News Detail
Loading, please wait...

TOCA Latest Social Stream

Loading social stream, please wait...

View Full TOCA Social Stream

Latest TOCA News From Around the Web

Below are the latest news stories about Tocagen Inc that investors may wish to consider to help them evaluate TOCA as an investment opportunity.

Tocagen Announces Change to Virtual Format for Special Meeting of Stockholders

Tocagen Inc. (Nasdaq: TOCA), historically a clinical-stage, cancer-selective gene therapy company, announced today that, due to public health and safety concerns related to the COVID-19 global pandemic, recommendations and orders from federal, state and local authorities, and to support the health and well-being of its stockholders, employees and others, it is changing its special meeting of stockholders related to its previously announced proposed merger with Forte Biosciences, Inc. (the "Special Meeting") to a virtual-only format that will be held via live audio webcast.

Yahoo | May 28, 2020

Tocagen Reports First Quarter 2020 Financial Results

SAN DIEGO, April 23, 2020 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), historically a clinical-stage, cancer-selective gene therapy company, today reported financial results for the first quarter ended March 31, 2020. On February 19, 2020, Tocagen announced it had entered into a…

PR Newswire | April 23, 2020

Tocagen Reports Fourth Quarter and Full Year 2019 Financial Results

SAN DIEGO, Feb. 27, 2020 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today reported financial results and business highlights for the fourth quarter and full year ended December 31, 2019. "Following our extensive review of…

PR Newswire | February 27, 2020

The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 19) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Akebia ...

Yahoo | February 20, 2020

Tocagen and Forte Biosciences Announce Merger

SAN DIEGO and TORRANCE, Calif., Feb. 19, 2020 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), and Forte Biosciences, Inc., a privately held clinical-stage biopharmaceutical company developing a live biotherapeutic for the treatment of inflammatory skin diseases, announced today that they…

PR Newswire | February 19, 2020

Read More 'TOCA' Stories Here

TOCA Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year 152.25%
5-year -90.59%
2022 N/A
2021 N/A
2020 0.00%
2019 -93.51%
2018 -19.90%

Continue Researching TOCA

Here are a few links from around the web to help you further your research on Tocagen Inc's stock as an investment opportunity:

Tocagen Inc (TOCA) Stock Price | Nasdaq
Tocagen Inc (TOCA) Stock Quote, History and News - Yahoo Finance
Tocagen Inc (TOCA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6821 seconds.